Shandong Weigao Group Medical Polymer Co's EBIT per Share for the
six
months ended in Dec. 2025 was $0.12.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.28.
During the past 12 months, the average EBIT per Share Growth Rate of Shandong Weigao Group Medical Polymer Co was -15.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -15.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -8.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 6.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
SHWGY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -15.2 Med: 16.4 Max: 70.2
Current: -15.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shandong Weigao Group Medical Polymer Co was 70.20% per year. The lowest was -15.20% per year. And the median was 16.40% per year.
SHWGY's 3-Year EBIT Growth Rate is ranked worse than 79.83% of 689
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs SHWGY: -15.20
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Shandong Weigao Group Medical Polymer Co EBIT per Share Related Terms
Shandong Weigao Group Medical Polymer Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co EBIT per Share Chart
Shandong Weigao Group Medical Polymer Co Annual Data
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co (SHWGY) has a EBIT per Share of $0.28 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #550 out of 689 companies in the Medical Devices & Instruments industry, placing it in the top 79.8%.
Is Shandong Weigao Group Medical Polymer Co's EBIT per Share too high?
Shandong Weigao Group Medical Polymer Co's current EBIT per Share is $0.28. The Medical Devices & Instruments industry median EBIT per Share is 9.40. Shandong Weigao Group Medical Polymer Co's value of $0.28 is 97% below this industry median. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #550 out of 689 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #550 out of 689 companies for EBIT per Share. This places Shandong Weigao Group Medical Polymer Co in the lower half of its industry. The industry median EBIT per Share is 9.40. Shandong Weigao Group Medical Polymer Co's value of $0.28 is 97% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current EBIT per Share of $0.28 is 97% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current EBIT per Share is $0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.01, compared to a current price of $1.60 — trading 47% below its estimated fair value. The current EBIT per Share is $0.28 and 97% below the Medical Devices & Instruments industry median of 9.40. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current EBIT per Share is $0.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $1.60 is trading 47% below its estimated GF Value™ of $3.01.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGY:
EBIT per Share: $0.28
GF Value™: $3.01 vs. price of $1.60 (47% below fair value)
Industry Position: 97% below the Medical Devices & Instruments median (#550 of 689)
No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score
Get the complete analysis for SHWGY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGY has been successfully added to your 
